In a phase III trial, the investigational subcutaneous monoclonal antibody elegrobart demonstrated greater reduction in proptosis compared to placebo in patients with active thyroid eye disease. Additionally, 51% of patients…
Hormonal contraception, including birth control pills and intrauterine devices (IUDs), is not associated with an increased prevalence of a brain pressure disorder called idiopathic intracranial hypertension, according to a meta-analysis…
A new research published in the Journal of Dentistry revealed that weekly application of silver diamine fluoride (SDF) provides better protection against enamel erosion when compared to daily sodium fluoride…
Spain: A study published in the European Respiratory Journal reports that saline lavage alone may prolong pleural drainage in patients with pleural Infection compared with intrapleural enzyme therapy (IET). The…
Setidegrasib, an emerging targeted therapy, has shown promising efficacy in a phase I trial involving patients with previously treated advanced pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC)…
In this edition of STAT's AI Prognosis: How to be a 'productive' biotech AI company, with Insilico Medicine CEO Alex Zhavoronkov, and more.
A delayed FDA decision for Orca Bio, new questions about pharma-telehealth tie-ups, and more
The FDA is moving toward allowing compounding pharmacies to produce injectable peptides that were banned over significant safety concerns
Around 300 resident doctors are leaving their postgraduate seats in government medical colleges in Maharashtra every year, reportedly due to excessive workload and long duty hours, a recent report by…
Here are the top health stories for the day:NMC Approves 49 Additional DM and MCh Seats for 2025-26 After AppealsThrough a recent notice, the National Medical Commission (NMC) approved additional…